Article

TNAO opposes bill to allow ODs added surgical privileges

The Tennessee Academy of Ophthalmology (TNAO) opposes a recent bill that would allow optometrists to inject local anesthetic into the tissue surrounding the eye in order to perform surgery.

 

Nashville, TN-The Tennessee Academy of Ophthalmology (TNAO) has announced opposition to a recently filed bill that, as amended, would allow optometrists to inject local anesthetic into the tissue surrounding the eye in order to perform surgery.

Optometrists in Tennessee are currently restricted to using topical anesthetic to remove what they call “lumps and bumps.” The legislation would allow optometrists to perform more advanced surgical procedures that require an injectable anesthetic.

“This legislation would create an unnecessary risk to patients and is a threat to the quality of surgical care in Tennessee,” said Ben Mahan, MD, president of the TNAO. “Anytime a needle is placed near the eye, there are serious risks to the patient that require clinical experience and expert judgment. A surgical error of just a few millimeters can result in a punctured eyeball and catastrophic vision loss.”

A statewide survey of registered voters showed that Tennesseans overwhelmingly support a current state law that requires those performing eye surgeries, including laser eye correction procedures, to have a medical degree. The survey was conducted on behalf of the TNAO to gauge public awareness of the difference in training between ophthalmologists and optometrists, and also to test opinions on loosening the current regulations on who can perform eye surgical procedures.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.